LUNG CANCER - NON SMALL CELL SQUAMOUS

Clinical trials for LUNG CANCER - NON SMALL CELL SQUAMOUS explained in plain language.

Never miss a new study

Get alerted when new LUNG CANCER - NON SMALL CELL SQUAMOUS trials appear

Sign up with your email to follow new studies for LUNG CANCER - NON SMALL CELL SQUAMOUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New Two-Drug attack on advanced lung cancer enters testing

Disease control Recruiting now

This study is testing whether adding a new drug called petosemtamab to an existing immunotherapy (pembrolizumab) is safe and more effective for people newly diagnosed with advanced non-small cell lung cancer. It will involve about 180 adults whose cancer has spread and who have n…

Matched conditions: LUNG CANCER - NON SMALL CELL SQUAMOUS

Phase: PHASE2 • Sponsor: Merus B.V. • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

LUNG CANCER - NON SMALL CELL SQUAMOUS

Get alerted when new LUNG CANCER - NON SMALL CELL SQUAMOUS trials appear

New Two-Drug attack on advanced lung cancer enters testing